COVID-19 大流行期间肝移植和慢性肝病患者的管理：简要综述。
Management of Patients with Liver Transplant and Chronic Liver Diseases During COVID-19 Pandemic: A Brief Review.
机构信息
Liver transplantation Center, Tehran University of Medical Sciences, Tehran, Iran.
Division of Gastroenterology and Hepatology, Tehran University of Medical Sciences, Imam Khomeini Hospital Complex, Tehran, Iran.
出版信息
Arch Iran Med. 2020 Oct 1;23(10):713-717. doi: 10.34172/aim.2020.92.
The coronavirus associated disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has rapidly spread all around the world and became pandemic in March 2020. Data on liver transplantation and chronic liver disease during the pandemic has remained scarce, and there is little information on whether immunosuppressed patients are at higher risk of developing severe COVID-19 infection. This review provides information for health care providers who care for patients with liver transplantation and chronic liver diseases.
由 SARS-CoV-2 病毒引起的 2019 年冠状病毒病（COVID-19）已迅速在全球范围内传播，并于 2020 年 3 月成为大流行。大流行期间有关肝移植和慢性肝病的数据仍然很少，关于免疫抑制患者是否有更高的罹患严重 COVID-19 感染的风险的信息也很少。本综述为照顾肝移植和慢性肝病患者的医疗保健提供者提供了信息。
Zotero 插件